关于来自海洋天然产品的潜在抗抑郁药的最新情况
Priya P Shejul1, Radhika K Raheja2, Gaurav M Doshi1
1Department of Pharmacology, Toxicology and Therapeutics SVKM's Dr. Bhanuben Nanavati College of Pharmacy, V.M. Road, Vile Parle (W), Mumbai, 400056, India.
海洋化合物显示出作为新型抗抑郁药的前景,为现有药物提供了具有显著副作用的替代品. 研究强调了它们通过向神经炎症和神经递质通路来治疗抑郁症的潜力.
科学领域:
- 海洋生物学 海洋生物学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抑郁症是影响数百万人的全球健康问题,目前的治疗方法具有显著的不良影响.
- 世界卫生组织指出,抑郁症是全球导致残疾的主要原因.
结论:
- 海洋衍生化合物在改变抑郁症的行为和生化标志物方面表现出临床前和临床疗效.
- 对这些化合物的作用机制和体内潜力的进一步研究对于新疗法开发是有必要的.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
